Coastline Trust Co cut its holdings in Danaher Co. (NYSE:DHR) by 12.7% in the third quarter, HoldingsChannel reports. The institutional investor owned 7,820 shares of the conglomerate’s stock after selling 1,135 shares during the quarter. Coastline Trust Co’s holdings in Danaher were worth $1,684,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Provident Wealth Management LLC purchased a new stake in Danaher in the third quarter valued at about $27,000. Howe & Rusling Inc. raised its stake in Danaher by 81.4% in the second quarter. Howe & Rusling Inc. now owns 156 shares of the conglomerate’s stock valued at $28,000 after buying an additional 70 shares during the last quarter. Semmax Financial Advisors Inc. purchased a new stake in Danaher in the second quarter valued at about $35,000. Trustcore Financial Services LLC raised its stake in Danaher by 36.9% in the second quarter. Trustcore Financial Services LLC now owns 230 shares of the conglomerate’s stock valued at $41,000 after buying an additional 62 shares during the last quarter. Finally, Prestige Wealth Management Group LLC raised its stake in Danaher by 1,055.6% in the first quarter. Prestige Wealth Management Group LLC now owns 312 shares of the conglomerate’s stock valued at $43,000 after buying an additional 285 shares during the last quarter. Institutional investors own 78.01% of the company’s stock.

Shares of DHR stock opened at $227.45 on Friday. The company has a current ratio of 2.20, a quick ratio of 1.74 and a debt-to-equity ratio of 0.68. Danaher Co. has a twelve month low of $119.60 and a twelve month high of $229.45. The stock has a 50 day moving average of $209.83 and a 200 day moving average of $183.29. The stock has a market cap of $161.36 billion, a P/E ratio of 48.70, a P/E/G ratio of 3.52 and a beta of 0.88.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Thursday, July 23rd. The conglomerate reported $1.44 EPS for the quarter, beating the consensus estimate of $1.09 by $0.35. Danaher had a return on equity of 11.88% and a net margin of 17.73%. The company had revenue of $5.30 billion for the quarter, compared to analyst estimates of $5.01 billion. During the same period last year, the company earned $1.09 earnings per share. Danaher’s quarterly revenue was up 2.7% compared to the same quarter last year. On average, research analysts predict that Danaher Co. will post 5.48 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Monday, September 28th will be issued a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 0.32%. The ex-dividend date is Friday, September 25th. Danaher’s payout ratio is currently 16.29%.

A number of equities research analysts have commented on the company. Bank of America increased their price target on Danaher from $181.00 to $215.00 and gave the company a “buy” rating in a research note on Monday, July 20th. Zacks Investment Research upgraded Danaher from a “hold” rating to a “buy” rating and set a $203.00 price objective for the company in a research note on Tuesday, July 21st. Wells Fargo & Company restated a “buy” rating and issued a $234.00 price objective on shares of Danaher in a research note on Tuesday, September 29th. Royal Bank of Canada raised their price objective on Danaher from $205.00 to $218.00 and gave the stock an “outperform” rating in a research note on Friday, July 24th. Finally, Jefferies Financial Group raised their price objective on Danaher from $190.00 to $230.00 and gave the stock a “buy” rating in a research note on Friday, July 24th. One equities research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. Danaher presently has a consensus rating of “Buy” and an average price target of $202.00.

In other news, Director John T. Schwieters sold 6,014 shares of Danaher stock in a transaction that occurred on Friday, July 24th. The stock was sold at an average price of $193.95, for a total value of $1,166,415.30. Following the sale, the director now directly owns 25,394 shares of the company’s stock, valued at $4,925,166.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Linda P. Hefner sold 2,754 shares of Danaher stock in a transaction that occurred on Monday, July 27th. The stock was sold at an average price of $197.00, for a total value of $542,538.00. Following the completion of the sale, the director now directly owns 32,749 shares in the company, valued at $6,451,553. The disclosure for this sale can be found here. Over the last three months, insiders sold 530,474 shares of company stock worth $104,501,669. 11.70% of the stock is owned by corporate insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments; Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Further Reading: How interest rates affect municipal bond prices

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.